Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Determinants of each domain of the Short Physical Performance Battery in COPD.

Bernabeu-Mora R, Giménez-Giménez LM, Montilla-Herrador J, García-Guillamón G, García-Vidal JA, Medina-Mirapeix F.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 23;12:2539-2544. doi: 10.2147/COPD.S138402. eCollection 2017.

2.

The Short Physical Performance Battery is a discriminative tool for identifying patients with COPD at risk of disability.

Bernabeu-Mora R, Medina-Mirapeix F, Llamazares-Herrán E, García-Guillamón G, Giménez-Giménez LM, Sánchez-Nieto JM.

Int J Chron Obstruct Pulmon Dis. 2015 Dec 3;10:2619-26. doi: 10.2147/COPD.S94377. eCollection 2015. Erratum in: Int J Chron Obstruct Pulmon Dis. 2016;11:623.

3.

Short-term prognostic value of forced expiratory volume in 1 second divided by height cubed in a prospective cohort of people 80 years and older.

Turkeshi E, Vaes B, Andreeva E, Matheï C, Adriaensen W, Van Pottelbergh G, Degryse JM.

BMC Geriatr. 2015 Feb 25;15:15. doi: 10.1186/s12877-015-0013-4.

4.

Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial.

Beeh KM, Watz H, Puente-Maestu L, de Teresa L, Jarreta D, Caracta C, Garcia Gil E, Magnussen H.

BMC Pulm Med. 2014 Dec 23;14:209. doi: 10.1186/1471-2466-14-209.

5.

Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease.

Roberts MH, Mapel DW, Bruse S, Petersen H, Nyunoya T.

Am J Epidemiol. 2013 Oct 1;178(7):1150-60. doi: 10.1093/aje/kwt087. Epub 2013 Aug 8.

6.

Lifetime socioeconomic inequalities in physical and cognitive aging.

Hurst L, Stafford M, Cooper R, Hardy R, Richards M, Kuh D.

Am J Public Health. 2013 Sep;103(9):1641-8. doi: 10.2105/AJPH.2013.301240. Epub 2013 Jul 18.

7.

Impact of risk factors, activities and psychological disorders on the health of patients with chronic obstructive pulmonary disease in China: a cross-sectional study.

Zhang L, Lou P, Zhu Y, Chen P, Zhang P, Yu J, Zhang N, Chen N, Wu H, Zhao J.

BMC Public Health. 2013 Jul 2;13:627. doi: 10.1186/1471-2458-13-627.

8.

Risk adjustment for health care financing in chronic disease: what are we missing by failing to account for disease severity?

Omachi TA, Gregorich SE, Eisner MD, Penaloza RA, Tolstykh IV, Yelin EH, Iribarren C, Dudley RA, Blanc PD.

Med Care. 2013 Aug;51(8):740-7. doi: 10.1097/MLR.0b013e318298082f.

9.

Association Between Emphysema Score, Six-Minute Walk and Cardiopulmonary Exercise Tests in COPD.

Chen LF, Wang CH, Chou PC, Ho SC, Joa WC, Sheng TF, Kuo HP.

Open Respir Med J. 2012;6:104-10. doi: 10.2174/1874306401206010104. Epub 2012 Oct 2.

10.

Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial.

Beeh KM, Singh D, Di Scala L, Drollmann A.

Int J Chron Obstruct Pulmon Dis. 2012;7:503-13. doi: 10.2147/COPD.S32451. Epub 2012 Jul 31.

11.

Postural Control Is Impaired in People with COPD: An Observational Study.

Roig M, Eng JJ, Macintyre DL, Road JD, Reid WD.

Physiother Can. 2011 Fall;63(4):423-31. doi: 10.3138/ptc.2010-32. Epub 2011 Oct 20.

12.

Limited lung function: impact of reduced peak expiratory flow on health status, health-care utilization, and expected survival in older adults.

Roberts MH, Mapel DW.

Am J Epidemiol. 2012 Jul 15;176(2):127-34. doi: 10.1093/aje/kwr503. Epub 2012 Jun 28.

13.

Relationship of obesity with respiratory symptoms and decreased functional capacity in adults without established COPD.

Zutler M, Singer JP, Omachi TA, Eisner M, Iribarren C, Katz P, Blanc PD.

Prim Care Respir J. 2012 Jun;21(2):194-201. doi: 10.4104/pcrj.2012.00028.

14.

Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking?

van den Borst B, Koster A, Yu B, Gosker HR, Meibohm B, Bauer DC, Kritchevsky SB, Liu Y, Newman AB, Harris TB, Schols AM.

Thorax. 2011 Nov;66(11):961-9. doi: 10.1136/thoraxjnl-2011-200010. Epub 2011 Jul 1.

15.

Development of disability in chronic obstructive pulmonary disease: beyond lung function.

Eisner MD, Iribarren C, Blanc PD, Yelin EH, Ackerson L, Byl N, Omachi TA, Sidney S, Katz PP.

Thorax. 2011 Feb;66(2):108-14. doi: 10.1136/thx.2010.137661. Epub 2010 Nov 3.

16.

Association of lung function with physical, mental and cognitive function in early old age.

Singh-Manoux A, Dugravot A, Kauffmann F, Elbaz A, Ankri J, Nabi H, Kivimaki M, Sabia S.

Age (Dordr). 2011 Sep;33(3):385-92. doi: 10.1007/s11357-010-9189-x. Epub 2010 Sep 29.

17.

COPD and cognitive impairment: the role of hypoxemia and oxygen therapy.

Thakur N, Blanc PD, Julian LJ, Yelin EH, Katz PP, Sidney S, Iribarren C, Eisner MD.

Int J Chron Obstruct Pulmon Dis. 2010 Sep 7;5:263-9.

18.

Influence of anxiety on health outcomes in COPD.

Eisner MD, Blanc PD, Yelin EH, Katz PP, Sanchez G, Iribarren C, Omachi TA.

Thorax. 2010 Mar;65(3):229-34. doi: 10.1136/thx.2009.126201.

19.

Measurement of COPD severity using a survey-based score: validation in a clinically and physiologically characterized cohort.

Eisner MD, Omachi TA, Katz PP, Yelin EH, Iribarren C, Blanc PD.

Chest. 2010 Apr;137(4):846-51. doi: 10.1378/chest.09-1855. Epub 2009 Dec 29.

20.

Socioeconomic status, race and COPD health outcomes.

Eisner MD, Blanc PD, Omachi TA, Yelin EH, Sidney S, Katz PP, Ackerson LM, Sanchez G, Tolstykh I, Iribarren C.

J Epidemiol Community Health. 2011 Jan;65(1):26-34. doi: 10.1136/jech.2009.089722. Epub 2009 Oct 23.

Supplemental Content

Support Center